SCHEMBL2344985

SCHEMBL2344985

Clc1cccc(C2CC3(CCNCC3)C2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 3/20 0.48
SLC6A2 P23975 2/20 0.48
KDM1A O60341 2/20 0.41
MAOB P27338 1/20 0.41
RCOR1 Q9UKL0 1/20 0.40
HTR2C P28335 4/20 0.39
HTR6 P50406 2/20 0.39
HTR2A P28223 2/20 0.39
HTR2B P41595 2/20 0.39
TP53 P04637 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 2/20 0.39
HTR1A P08908 2/20 0.39
SLC6A4 P31645 2/20 0.39
HTR3E A5X5Y0 1/20 0.39
HTR3B O95264 1/20 0.39
ADRB1 P08588 1/20 0.39
CYP3A4 P08684 1/20 0.39
THRB P10828 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2344900 0.79 HTR2C (0.64) SLC6A3KDM1AMAOBHTR2CHTR2A
SCHEMBL23859719 0.79 KDM1A (0.55) KDM1AMAOBTP53CYP1A2CYP2D6
Hydrochloric Acid SCHEMBL2341474 0.78 SLC6A2 (0.50) SLC6A3SLC6A2CYP2D6SLC6A4DRD2
SCHEMBL18423505 0.78 SLC6A3 (0.43) SLC6A3SLC6A2KDM1ARCOR1HTR2C
SCHEMBL613293 0.78 HTR2C (0.62) SLC6A3SLC6A2HTR2CHTR1ASLC6A4
Hydrochloric Acid SCHEMBL2349090 0.77 SLC6A2 (0.50) SLC6A3SLC6A2CYP2D6SLC6A4
Hydrochloric Acid SCHEMBL2425833 0.77 SLC6A2 (0.42) SLC6A3SLC6A2KDM1ARCOR1HTR2C
Hydrochloric Acid SCHEMBL2434241 0.77 SLC6A2 (0.42) SLC6A3SLC6A2KDM1ARCOR1HTR2C
Hydrochloric Acid SCHEMBL1458622 0.76 HTR2C (0.64) SLC6A3SLC6A2HTR2CHTR1ASLC6A4
Hydrochloric Acid SCHEMBL2342153 0.76 HTR2C (0.41) SLC6A2KDM1AMAOBHTR2CCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2358704-A1 7-azaspiro [3.5]nonane-7-carboxamide compounds as modulators of fatty acid amide hydrolase Pfizer Inc. (US) 2011-08-24 EP disclosed
US-20100113465-A1 7-AZASPIRO[3.5]NONANE-7-CARBOXAMIDE COMPOUNDS PFIZER INC. 2010-05-06 US disclosed
WO-2010049841-A1 7-AZASPIRO [3.5] NONANE-7-CARBOXAMIDE COMPOUNDS AS MODULATORS OF FATTY ACID AMIDE HYDROLASE PFIZER INC. (US) 2010-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113465-A1 7-AZASPIRO[3.5]NONANE-7-CARBOXAMIDE COMPOUNDS FAAH, FAAH2, APEH SLC6A3 1799/4885SLC6A2 1124/4885KDM1A 331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.